CurrentEndo coverage · page 12 of 33

Cardiovascular Diabetology

Briefs 441–480 of 1,291 CurrentEndo has covered from this journal, newest publication first

Latest from Cardiovascular Diabetology

All coverage, newest first

Cardiovasc Diabetol6 Jun 2025
Treatment with orforglipron, an oral glucagon like peptide-1 receptor agonist, is associated with improvements of CV risk biomarkers in participants with type 2 diabetes or obesity without diabetes
Secondary analysisT2D & other
Cardiovasc Diabetol6 Jun 2025
Causal association of modifiable factors with cardiometabolic multimorbidity: an exposome-wide Mendelian randomization investigation
Research articleT2D & other
Cardiovasc Diabetol4 Jun 2025
Pseudohypoxia caused by germline genetic alterations in the VHL gene is associated with increased diabetes and cardiovascular risk: a UK biobank study
Cohort studyT2D & other
Cardiovasc Diabetol4 Jun 2025
Sex-specific cardiometabolic multimorbidity, metabolic syndrome and left ventricular function in heart failure with preserved ejection fraction in the UK Biobank
Cross-sectional study
Cardiovasc Diabetol31 May 2025
Tenascin-C drives cardiovascular dysfunction in a mouse model of diabetic cardiomyopathy
Mechanistic studyComplications
Cardiovasc Diabetol31 May 2025
Statin-induced risk of diabetes does not reduce cardiovascular benefits in primary prevention: a 6-year propensity-score matched study in a large population
Cohort studyT2D & other
Cardiovasc Diabetol30 May 2025
Effects of dapagliflozin on the progression of left ventricular dysfunction in type 2 diabetes mellitus: a randomized controlled trial
Randomized controlled trialT2D & other
Cardiovasc Diabetol29 May 2025
Increased prevalence and risk of atherosclerotic cardiovascular disease in individuals with Type 1 diabetes and metabolic dysfunction-associated steatotic liver disease
Cross-sectional studyT1D
Cardiovasc Diabetol26 May 2025
Comparison of right ventricular function and clinical outcomes in type 2 diabetes patients with and without obstructive coronary artery disease: insights from a CMR study
Cohort studyT2D & other
Cardiovasc Diabetol24 May 2025
Cumulative blood pressure load as a predictor of arterial stiffness progression and incident diabetic kidney disease: a multicenter longitudinal study
Cohort studyComplications
Cardiovasc Diabetol24 May 2025
Metabolic profiling of frailty, associations with type 2 diabetes and interaction with genetic susceptibility
Cohort studyT2D & other
Cardiovasc Diabetol21 May 2025
Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI)
Cohort studyT2D & other
Cardiovasc Diabetol21 May 2025
Cardiovascular risk profile in subjects with diabetes: Is SCORE2-Diabetes reliable?
Cross-sectional studyT2D & other
Cardiovasc Diabetol21 May 2025
Association between atherogenicity indices and prediabetes: a 5-year retrospective cohort study in a general Chinese physical examination population
Cohort studyT2D & other
Cardiovasc Diabetol21 May 2025
Association between the atherogenic index of plasma and incident hypertension across different blood pressure states: a national cohort study
Cohort studyLipids & liver
Cardiovasc Diabetol21 May 2025
The predictive significance of the triglyceride-glucose index in forecasting adverse cardiovascular events among type 2 diabetes mellitus patients with co-existing hyperuricemia: a retrospective cohort study
Cohort studyT2D & other
Cardiovasc Diabetol19 May 2025
The role of diabetes mellitus on delirium onset: a systematic review and meta-analysis
Meta-analysisT2D & other
Cardiovasc Diabetol16 May 2025
Effect of glycemic status on myocardial deformation and microvascular function in uncomplicated pediatric type 1 diabetes mellitus: cardiac magnetic resonance imaging
Cross-sectional studyT1D
Cardiovasc Diabetol15 May 2025
A validated multivariable machine learning model to predict cardio-kidney risk in diabetic kidney disease
Diagnostic or prognostic studyComplications
Cardiovasc Diabetol14 May 2025
Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets
Mechanistic studyComplications
Cardiovasc Diabetol14 May 2025
Atherogenic lipid parameters in people with normal glucose tolerance: implications from elevated 1-hour post-load plasma glucose
Cross-sectional studyLipids & liver
Cardiovasc Diabetol14 May 2025
Sacubitril/Valsartan attenuates progression of diabetic cardiomyopathy through immunomodulation properties: an opportunity to prevent progressive disease
Mechanistic studyComplications
Cardiovasc Diabetol14 May 2025
Extracellular vesicle-associated miR-515-5p from adipose tissue regulates placental metabolism and fetal growth in gestational diabetes mellitus
Case-control studyDiabetes in pregnancy
Cardiovasc Diabetol14 May 2025
How does biological age acceleration mediate the associations of obesity with cardiovascular disease? Evidence from international multi-cohort studies
Cohort studyObesity
Cardiovasc Diabetol14 May 2025
Use of an insulin titration protocol based on continuous glucose monitoring in postoperative cardiac surgery patients with type 2 diabetes and prediabetes: a randomized controlled trial
Randomized controlled trialTechnology
Cardiovasc Diabetol13 May 2025
Diabetes mellitus aggravates myocardial inflammation and oxidative stress in aortic stenosis: a mechanistic link to HFpEF features
Mechanistic studyComplications
Cardiovasc Diabetol12 May 2025
Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0–3: a nationwide prospective cohort study
Cohort study
Cardiovasc Diabetol12 May 2025
Circulating mediators linking cardiometabolic diseases to HFpEF: a mediation Mendelian randomization analysis
Research articleT2D & other
Cardiovasc Diabetol9 May 2025
Combined assessment of stress hyperglycemia ratio and glycemic variability to predict all-cause mortality in critically ill patients with atherosclerotic cardiovascular diseases across different glucose metabolic states: an observational cohort study with machine learning
Cohort studyT2D & other
Cardiovasc Diabetol9 May 2025
Effects of empagliflozin on functional capacity, LV filling pressure, and cardiac reserves in patients with type 2 diabetes mellitus and heart failure with preserved ejection fraction: a randomized controlled open-label trial
Randomized controlled trialT2D & other
Cardiovasc Diabetol9 May 2025
Metabolic pathways mediating insulin resistance and gestational diabetes mellitus discovered by high-dimensional systematic Mendelian randomization
Case-control studyDiabetes in pregnancy
Cardiovasc Diabetol9 May 2025
The association between different insulin resistance surrogates and all-cause mortality and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease
Cohort studyLipids & liver
Cardiovasc Diabetol9 May 2025
Long-term dual-trajectories of TyG and LAP and their association with cardiometabolic multimorbidity in midlife: the CARDIA study
Cohort studyT2D & other
Cardiovasc Diabetol9 May 2025
Life’s Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China
Cohort study
Cardiovasc Diabetol6 May 2025
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular outcomes in older adults with type 2 diabetes mellitus: a target trial emulation study
Research articleT2D & other
Cardiovasc Diabetol3 May 2025
Epicardial Adipose Tissue and Heterogeneity Parameters Combined with Inflammatory Cells to Predict the Value of Heart Failure with Preserved Ejection Fraction Patients Post Myocardial Infarction
Cohort study
Cardiovasc Diabetol3 May 2025
Association of obesity- and insulin resistance-related indices with subclinical carotid atherosclerosis in type 1 diabetes: a cross-sectional study
Cross-sectional studyT1D
Cardiovasc Diabetol2 May 2025
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes
Research article
Cardiovasc Diabetol2 May 2025
Impact of baseline left ventricular ejection fraction and body mass index on the effect of 24-week Ipragliflozin treatment on left ventricular diastolic function in patients with type 2 diabetes and chronic kidney disease: insights from the PROCEED trial
Secondary analysisT2D & other
Cardiovasc Diabetol2 May 2025
Relationship between stress hyperglycaemic ratio (SHR) and critical illness: a systematic review
Meta-analysis

All 1,291 Briefs in ExploreShowing Briefs 441–480 of 1,291, newest first